Skip to main navigation Skip to main content
  • E-Submission
  • Contact us

NS : Neurospine

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

1
results for

"Qing-yue Liang"

Article category

Publication year

Keywords

Authors

Funded articles

"Qing-yue Liang"

Review Article

Spinal Cord Injury INTS-Neurospine Special Issue

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

Include:

Multimodal Repair of Spinal Cord Injury With Mesenchymal Stem Cells
Neurospine. 2022;19(3):616-629.   Published online September 30, 2022
Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:
Include:
Multimodal Repair of Spinal Cord Injury With Mesenchymal Stem Cells
Neurospine. 2022;19(3):616-629.   Published online September 30, 2022
Close
Spinal cord injury (SCI) is a result of a devastating injury to the central nervous system. Currently, there is no effective treatment available for these patients. The possible use of mesenchymal stem cell (MSC)-based treatment for SCI has been the focus of extensive investigations and is increasingly moving from the bench to bedside. Both experimental observations and clinical studies have shown the safety and efficacy of MSCs in managing SCI. However, the exact mechanism by which MSCs contribute to the repair of the injured spinal cord remains to be elucidated. In this review, we aim to summarize current research findings about the role of MSCs in improving complex pathology after SCI. MSCs exert a multimodal repair mechanism targeting multiple events in the secondary injury cascade. Our recent results showing the perineurium-like differentiation of surviving MSCs in the injured spinal cord may further the understanding of the fate of transplanted MSCs. These findings provide fundamental support for the clinical use of MSCs in SCI patients. Under experimental conditions, combining novel physical, chemical, and biological approaches led to significant improvements in the therapeutic efficacy of MSCs. These findings hold promise for the future of cell-based clinical treatment of SCI.

Citations

Citations to this article as recorded by  Crossref logo
  • Nanozyme-Switched Efferocytosis Initiation Platform Orchestrates Pathological Network Reprogramming to Promote Functional Recovery after Spinal Cord Injury
    Chang Li, Zheng Cheng, Yanwei He, Chuchu Ma, Yinzhe Sun, Weili Han, Jianing Gong, Xiaoying Xie, Peiqi Huang, Fenfen Ma, Zhihua Wang, Honglian Zhao, Sijian Pan, Shiqiang Tong, Jun Chen
    ACS Nano.2026; 20(20): 14890.     CrossRef
  • Neuroinflammation: targeting microglia for neuroprotection and repair after spinal cord injury
    Roberta Ramos Cavalcanti, Fernanda Martins Almeida, Ana Maria Blanco Martinez, Camila Marques Freria
    Frontiers in Immunology.2025;[Epub]     CrossRef
  • Stem Cell and Regenerative Therapies for the Treatment of Osteoporotic Vertebral Compression Fractures
    Songzi Zhang, Yunhwan Lee, Yanting Liu, Yerin Yu, Inbo Han
    International Journal of Molecular Sciences.2024; 25(9): 4979.     CrossRef
  • Therapeutic Transplantation of Human Central Nervous System Organoids for Neural Reconstruction
    Sung Jun Hong, Minsung Bock, Songzi Zhang, Seong Bae An, Inbo Han
    International Journal of Molecular Sciences.2024; 25(15): 8540.     CrossRef
  • Innovative Strategies in 3D Bioprinting for Spinal Cord Injury Repair
    Daniel Youngsuk Kim, Yanting Liu, Gyubin Kim, Seong Bae An, Inbo Han
    International Journal of Molecular Sciences.2024; 25(17): 9592.     CrossRef
  • Repeated intrathecal injections of peripheral nerve-derived stem cell spheroids improve outcomes in a rat model of traumatic brain injury
    Hae Eun Shin, Won-Jin Lee, Kwang-Sook Park, Yerin Yu, Gyubin Kim, Eun Ji Roh, Byeong Gwan Song, Joon-Hyuk Jung, Kwangrae Cho, Young-hu Ha, Young-Il Yang, Inbo Han
    Stem Cell Research & Therapy.2024;[Epub]     CrossRef
  • Modulation of the LIMK Pathway by Myricetin: A Protective Strategy Against Neurological Impairments in Spinal Cord Injury
    Abhishek Roy, Santimoy Sen, Rudradip Das, Amit Shard, Hemant Kumar
    Neurospine.2024; 21(3): 878.     CrossRef
  • Induced neural stem cells suppressed neuroinflammation by inhibiting the microglial pyroptotic pathway in intracerebral hemorrhage rats
    Jiaxin Liu, Chuanshang Cao, Yiran Jin, Yan Wang, Xiaona Ma, Jiahui Li, Songlin Guo, Jiancheng Yang, Jianguo Niu, Xueyun Liang
    iScience.2023; 26(7): 107022.     CrossRef
  • Different Ways to Die: Cell Death Pathways and Their Association With Spinal Cord Injury
    Lahanya Guha, Nidhi Singh, Hemant Kumar
    Neurospine.2023; 20(2): 430.     CrossRef
  • Commentary on “Different Ways to Die: Cell Death Pathways and Their Association With Spinal Cord Injury”
    Jeffrey Luo, Joshua B. Stein, Ki-Bum Lee
    Neurospine.2023; 20(2): 449.     CrossRef
  • Intensive neurorehabilitation and allogeneic stem cells transplantation in canine degenerative myelopathy
    Débora Gouveia, Jéssica Correia, Ana Cardoso, Carla Carvalho, Ana Catarina Oliveira, António Almeida, Óscar Gamboa, Lénio Ribeiro, Mariana Branquinho, Ana Sousa, Bruna Lopes, Patrícia Sousa, Alícia Moreira, André Coelho, Alexandra Rêma, Rui Alvites, Antón
    Frontiers in Veterinary Science.2023;[Epub]     CrossRef
  • Safety and Feasibility of Intradiscal Administration of Matrilin-3-Primed Adipose-Derived Mesenchymal Stromal Cell Spheroids for Chronic Discogenic Low Back Pain: Phase 1 Clinical Trial
    Dong Hyun Lee, Kwang-Sook Park, Hae Eun Shin, Sung Bum Kim, Hyejeong Choi, Seong Bae An, Hyemin Choi, Joo Pyung Kim, Inbo Han
    International Journal of Molecular Sciences.2023; 24(23): 16827.     CrossRef
  • 9,051 View
  • 247 Download
  • 13 Web of Science
  • 12 Crossref